Skip to main content
letter
. 2016 Sep 1;115(7):825–830. doi: 10.1038/bjc.2016.266

Table 1. Clinical characteristics, RAD 51 status and treatment response of patients.

Trial no. Stage HPV status Smoking status (pack years) Prognostic group Difference in RAD51 foci pre- and post-IC (%) RAD 51 status Treatment response
1002 T2N2B −ve 30 Poor 31 Positive CR
1003 T4N2B +ve 20 Intermediate 25 Positive CR
1004 T4N2B −ve 40 Poor 7 Negative PR
1005 T2N2B −ve 20 Poor 3 Negative PR
1006 T2N2B +ve Never Good 62 Positive CR
1007 T2N1 +ve Never Good 44 Positive CR
1008 T3N2B +ve 30 Intermediate 71 Positive CR
1009 T3N0 +ve 15 Good 74 Positive CR
1010 T4N2C +ve 30 Intermediate 27 Positive CR
1011 T3N2B +ve 30 Intermediate 72 Positive CR
1013 T4N2B −ve 40 Poor 3 Negative PR
1014 T2N2B −ve 40 Poor 27 Positive CR
1015 T3N2B +ve Never Good 57 Positive CR

Abbreviations: CR=complete response; HPV=human papilloma virus; PR=partial response.